💥 New Year offer – Free shipping, On above 500 Rs purchase.
Indication
Looking for relief from painful piles? Arsho Norm Tablet offers a natural approach to easing discomfort and inflammation.
MRP
₹175.00 inc. GST
Prepaid shipping charge: ₹70 (for orders below ₹500)
Dosage
Description
Arsho Norm Tablet provides targeted relief from pain, inflammation, and bleeding associated with piles. Its natural Ayurvedic formula soothes discomfort and supports smoother digestion, offering a safe, effective solution for daily comfort.
Composition
| Each 500 mg contains: | ||
|---|---|---|
| Gandhaka | 62.5 mg | |
| Harithaki | Terminalia chebula | 62.5 mg |
| Lajjalu | Mimosa pudica | 62.5 mg |
| Shunti | Zingiber officinale | 62.5 mg |
| Chithraka | Plumbago zeylanica | 62.5 mg |
| Punamava | Boerrhavia diffusa | 62.5 mg |
| Vidanga | Embelica diffusa | 62.5 mg |
| Karanja | Pongamia glabra | 62.5 mg |
Gandhaka
Known for its anti-inflammatory effects, helping reduce swelling and pain.
Harithaki
Supports digestion and helps ease painful evacuations.
Lajjalu
Helps reduce bleeding and soothes irritated tissues.
Shunti (Ginger)
Relieves inflammation and discomfort during bowel movements.
Chithraka
Stimulates digestion and aids in managing pile symptoms.
Punarnava
Known for its calming properties, it supports natural healing.
Vidanga
Alleviates pain and discomfort.
Karanja
Reduces itching and irritation, promoting overall comfort.
Presentation
100 tablets pack, 1000 tablets jar
Reviews
₹80.00 inc. GST
₹80.00 inc. GST
₹180.00 inc. GST
₹105.00 inc. GST
₹175.00 inc. GST
Embracing the ancient wisdom of Ayurveda, SDP Ayurveda has been a beacon of holistic well-being for over three decades. Our legacy is rooted in authentic practices, ensuring a harmonious balance between body, mind, and spirit.
For Product Enquiries
Stay connected and embrace the journey of well-being with SDP Ayurveda. Subscribe to our newsletter for the latest updates, wellness tips, and more.
Contact Information
Awards and Certifications
Reviews
There are no reviews yet.